TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 2 | 3 | -2 | -18 | -28 | -19 | -47 | -18 |
S | %wins | 0 | 100 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/25/08 21:12 | 9/23/08 | ENZ | Enzo Biochem Inc | NY | Health | Health | Medical Laboratories | Kelker Norman E | NY | O | SVP | M.d | 66 | 5.45 | 3 | 12 | 12 | 111 | D | -13 | -9 | 22 | -7 | -24 | -11 | 7 | -4 | 1 | -2 | -54 | -63 | -62 | -36 |
12/21/07 16:04 | 12/20/07 | ENZ | Enzo Biochem Inc | NY | Health | Health | Medical Laboratories | Kelker Norman E | NY | O | SVP | S | -173 | 12.75 | 2 | -14 | -12 | 105 | D | 2 | -7 | -15 | 9 | 22 | 19 | 1 | 3 | 5 | -2 | -25 | -35 | -16 | -67 |
7/20/05 11:27 | 7/19/05 | ENZ | Enzo Biochem Inc | NY | Health | Health | Medical Laboratories | Kelker Norman E | NY | O | SVP | S | -166 | 16.60 | 2 | -10 | -8 | 114 | D | -14 | 22 | -9 | 20 | 14 | -6 | -4 | -2 | 1 | -1 | -10 | -21 | -21 | -27 |
5/31/05 21:17 | 5/26/05 | ENZ | Enzo Biochem Inc | NY | Health | Health | Medical Laboratories | Kelker Norman E | NY | O | SVP | M.d | 48 | 6.84 | 1 | 7 | 6 | 124 | D | -32 | 19 | -17 | -6 | 9 | 0 | -3 | -1 | 1 | -2 | 18 | -3 | -8 | -34 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |